Track the SCL사이언스 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, SCL사이언스 has recorded 53 public disclosures. Market capitalisation: €14.9bn. The latest transaction was reported on 27 May 2026 (Purchase). Among the most active insiders: 대신신기술투자조합제15호. The full history is openly available.
53
Insider Decl.
0
Thresholds
·
29 ops.
Buy Volume
·
1 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,644 of 26,270 companies
17.4
score / 100
Value
18
Quality
17
FCF yld-8.0%
Earn yld-6.8%
EV/EBITDA·
ROE-13%
Gross mgn19%
Net mgn-18%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.